With today's advanced treatments, HIV may be a more 'manageable' disease, but those with the condition now face a growing risk of HPV infections, some of which can become a precursor to cancer. Among the research in this field, a US study is looking at immunotherapy against anal warts and their effect on AIN in HIV/HPV co-infected subjects.
|Original language||English (US)|
|Journal||EBR - European Biopharmaceutical Review|
|State||Published - 2014|
ASJC Scopus subject areas
- Pharmaceutical Science